Place du linézolide dans la prise en charge de pneumonies nosocomiales à Staphylococcus aureus résistants à la méticilline (SARM)

The primary aim of this review is to provide an up-to-date evaluation of the clinical evidence for using linezolid to treat MRSA nosocomial pneumonia, with a focus on recently published studies. The second objective is to evaluate the cost-effectiveness of linezolid compared to other agents.